Senior insider sale
Chief Corp Dev & Strategy at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$183.4K
5.92K shares
What this filing means
VISWANADHAN KRISHNAN plans to sell 5.92K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $183.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/2/2026ACC: 0001439222-26-000053
Officer· Chief Corp Dev & Strategy
Since Mar 2026
5.92K
Shares to sell
$183.4K
Approx. market value
2.96K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
Not Applicable
4/2/2026
2.96KTotal acquired2.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/2/2026 | Vesting of Restricted Stock Units Not Applicable | 2.96K | — |
| Total | 2.96K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.96K
Market value
$82.3K
3/5/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
2.96K
Market value
$101.2K
4/2/2026
Total
Units
5.92K
Value
$183.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/5/2026 | 2.96K | $82.3K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2026 | 2.96K | $101.2K | Nasdaq | Planned |
| Total | 5.92K | $183.4K | ||